Infosys partners with IHH Healthcare on AI-powered ERP transformation

1 min read     Updated on 12 Jun 2026, 04:56 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Infosys has partnered with IHH Healthcare for a multi-year, AI-powered ERP transformation to standardize operations across key markets. The collaboration will consolidate finance, procurement, and supply chain functions using Infosys Topaz to enhance efficiency and data visibility.

powered bylight_fuzz_icon
42705092

*this image is generated using AI for illustrative purposes only.

Infosys has announced a strategic collaboration with IHH Healthcare to drive a multi-year, enterprise-wide ERP transformation program. The initiative aims to standardize and harmonize business processes across IHH Healthcare's global network, starting with Hong Kong, Malaysia, and Singapore. This partnership is designed to streamline operations, enhance agility, optimize costs, and strengthen regulatory compliance for the healthcare provider.

Partnership Overview

The collaboration leverages Infosys Topaz, an AI-first offering powered by generative and agentic AI technologies, to embed intelligence into IHH Healthcare's core business workflows. Infosys will consolidate the legacy, siloed ERP landscape by integrating critical functions such as finance, procurement, supply chain, human capital management, and enterprise performance management. This approach will help IHH Healthcare unlock AI-powered business value at scale and establish a centralized, digital enterprise foundation.

Parameter Details
Partnership Infosys and IHH Healthcare
Initiative Type AI-Powered ERP Transformation
Key Markets Hong Kong, Malaysia, Singapore
Primary Functions Finance, Procurement, Supply Chain, HCM, EPM

Strategic Focus

The AI-driven transformation is intended to address the operational complexities of managing a multi-country healthcare ecosystem. By integrating artificial intelligence into core enterprise systems, the partnership aims to deliver improved process efficiency and real-time data visibility. This will support IHH Healthcare's journey toward a more connected, data-driven, and future-ready healthcare ecosystem.

Dilip Kadambi, Group Chief Financial Officer, IHH Healthcare, stated that the collaboration will drive greater cost efficiency while empowering teams to focus on patient care. Venky Ananth, EVP and Global Head – Healthcare, Infosys, highlighted the ability to operationalize AI-led transformation at scale by consolidating fragmented systems into a unified, cloud-based platform.

Historical Stock Returns for Infosys

1 Day5 Days1 Month6 Months1 Year5 Years
+0.16%-7.07%-5.15%-30.14%-31.56%-22.84%

How will the success of this initial rollout in Hong Kong, Malaysia, and Singapore influence the timeline for expansion into IHH Healthcare's other global markets?

What specific cost savings or operational efficiency metrics is IHH Healthcare targeting to achieve within the first year of the ERP implementation?

How might the integration of generative AI into core workflows alter the workforce structure or require new skill sets within IHH Healthcare's finance and supply chain teams?

Infosys executives to attend CLSA India GenAI Access Days

0 min read     Updated on 09 Jun 2026, 04:44 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Infosys Limited announced that its management representatives will attend the CLSA India GenAI Access Days on June 15, 2026. The virtual meeting will feature senior executives discussing generative AI developments with investors. The event details will be available on the company's website.

powered bylight_fuzz_icon
42488735

*this image is generated using AI for illustrative purposes only.

Infosys Limited management representatives will participate in the CLSA India GenAI Access Days scheduled for June 15, 2026. The virtual group meeting will provide a platform for the company's leadership to engage with investors and discuss developments in the generative artificial intelligence space.

The participation involves senior executives who will represent the company during the session. This engagement is part of the company's ongoing investor relations activities to communicate its strategic initiatives and technological advancements.

The following executives are scheduled to participate in the event:

Name Designation
Satish H.C. Chief Delivery Officer
Mohammed Rafee Tarafdar Chief Technology Officer
Sandeep Mahindroo Financial Controller and Head - Investor Relations

The meeting details will be hosted on the company's official website for public access. This disclosure was submitted to the BSE Limited, National Stock Exchange of India Limited, and New York Stock Exchange on June 8, 2026.

Historical Stock Returns for Infosys

1 Day5 Days1 Month6 Months1 Year5 Years
+0.16%-7.07%-5.15%-30.14%-31.56%-22.84%

What specific generative AI initiatives or products is Infosys planning to showcase during the CLSA India GenAI Access Days?

How might Infosys' participation in this event influence investor sentiment regarding its AI capabilities and future growth prospects?

What competitive advantages could Infosys gain by highlighting its GenAI advancements to investors at this time?

More News on Infosys

1 Year Returns:-31.56%